Chloroquine phosphate
- Product NDC
- 63304-460
- 11-digit product format
- 633040460
- Labeler code
- 63304
- Product ID
- 63304-460_cfca0747-ed49-447d-be28-98c231a5c80d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Chloroquine phosphate
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Ranbaxy Pharmaceuticals Inc.
- Application
- ANDA090610
- Marketing category
- ANDA
- Marketing start
- 2011-03-15
- Marketing end
- 0000-00-00
- Substance
- CHLOROQUINE PHOSPHATE
- Active strength
- 250 mg/1
- Pharmacologic classes
- Antimalarial [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63304-460-03 | 2020-05-03 | C162847 | 48780-1 | 9d75b9d0-4a6b-f424-e053-dadaa90a57ce | f398f8a9-92f3-47cb-81c2-6078806a464d |
| 63304-460-10 | 2020-05-03 | C162847 | 48780-1 | 9d75b9d0-4a6b-f424-e053-dadaa90a57ce | f398f8a9-92f3-47cb-81c2-6078806a464d |
| 63304-460-50 | 2020-05-03 | C162847 | 48780-1 | 9d75b9d0-4a6b-f424-e053-dadaa90a57ce | f398f8a9-92f3-47cb-81c2-6078806a464d |
| 63304-460-03 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-4a6b-f424-e053-dadaa90a57ce | f398f8a9-92f3-47cb-81c2-6078806a464d |
| 63304-460-10 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-4a6b-f424-e053-dadaa90a57ce | f398f8a9-92f3-47cb-81c2-6078806a464d |
| 63304-460-50 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-4a6b-f424-e053-dadaa90a57ce | f398f8a9-92f3-47cb-81c2-6078806a464d |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63304-460-50 | EA - Each | 63304-460 | 2dd2b0ee-b1d8-462e-9f25-b19e8e5ae2b9 | 1 | 2013-02-13 |